机构地区:[1]School of Life Sciences, Jilin University, Changchun 130012, P.R.China [2]Clinical Pharmacology Center, Research Institute of Translational Medicine, the First Hospital of Jilin University, Changchun 130061, P.R.China [3]National Engineering Laboratory for AIDS Vaccine,the Ministry of Education,Jilin University, Changchun 130012, P.R.China [4]Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education,Jilin University, Changchun 130012, P.R.China [5]School of Pharmaceutical Sciences, Jilin University, Changchun 130021, P. R. China [6]School of Pharmacy, University of Otago, Dunedin 9054, New Zealand
出 处:《Chemical Research in Chinese Universities》2013年第6期1078-1082,共5页高等学校化学研究(英文版)
基 金:the National Natural Science Foundation of China,the Science and Technology Major Specialized Projects for "Significant New Drugs Creation" of the 12th Five-year Plan of China,the National Key Technology R&D Program of the Ministry of Science and Technology,China
摘 要:Astilbin is a potential immunosuppressive agent with minor cytotoxicity. Its oral bioavailability is supposed to be rather low and therefore a sensitive analytical method is required for its pharmacokinetic study after oral administration. A simple, sensitive and rapid liquid chromatography-tandem mass spectrometry(LC-MS/MS) method was developed and validated for the determination of astilbin in rat plasma. Plasma samples were subjected to liquid-liquid extraction with ethyl acetate and separated by reversed phase high performance liquid chromatography(HPLC) with methanol-0.01%(volume fraction) formic acid(50:50, volume ratio) as mobile phase. Quantitive determination was achieved on negative LC-MS/MS by a multiple reaction moitoring method with transitions m/z 449.1→150.9(quantifier) and m/z 449.1→284.9(qualifier) for astilbin and m/z 128.9→42.0 for internal standard(IS). A lower limit of quantification(LLOQ) of ng/mL was achieved within a short cycle time of 3.4 min. The method was successfully applied to a pharmacokinetic study involving oral and intravenous administrations of 6 mg/kg astilbin to six rats.Astilbin is a potential immunosuppressive agent with minor cytotoxicity. Its oral bioavailability is supposed to be rather low and therefore a sensitive analytical method is required for its pharmacokinetic study after oral administration. A simple, sensitive and rapid liquid chromatography-tandem mass spectrometry(LC-MS/MS) method was developed and validated for the determination of astilbin in rat plasma. Plasma samples were subjected to liquid-liquid extraction with ethyl acetate and separated by reversed phase high performance liquid chromatography(HPLC) with methanol-0.01%(volume fraction) formic acid(50:50, volume ratio) as mobile phase. Quantitive determination was achieved on negative LC-MS/MS by a multiple reaction moitoring method with transitions m/z 449.1→150.9(quantifier) and m/z 449.1→284.9(qualifier) for astilbin and m/z 128.9→42.0 for internal standard(IS). A lower limit of quantification(LLOQ) of ng/mL was achieved within a short cycle time of 3.4 min. The method was successfully applied to a pharmacokinetic study involving oral and intravenous administrations of 6 mg/kg astilbin to six rats.
关 键 词:ASTILBIN Liquid chromatography-tandem mass spectrometry(LC-MS/MS) PHARMACOKINETICS RAT Plasma
分 类 号:S859.796[农业科学—临床兽医学] O657.72[农业科学—兽医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...